Laurion Capital Management’s Evolent Health EVH Stock Holding History

Laurion Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32,968	Closed	-$415K	–	963
2019 Q1	$415K	Buy	+32,968	New	+$522K	0.01%	661
2018 Q2	–	Sell	-599,654	Closed	-$8.54M	–	1387
2018 Q1	$8.54M	Buy	+599,654	New	+$8.58M	0.07%	256
2017 Q4	–	Sell	-12,700	Closed	-$226K	–	1614
2017 Q3	$226K	Sell	12,700 -25,847	-67%	-$533K	﹤0.01%	1402
2017 Q2	$977K	Buy	+38,547	New	+$927K	0.01%	1037
2016 Q4	–	Sell	-112,500	Closed	-$2.77M	–	1153
2016 Q3	$2.77M	Buy	+112,500	New	+$2.63M	0.03%	416
2015 Q3	–	Sell	-85,000	Closed	-$1.66M	–	781
2015 Q2	$1.66M	Buy	+85,000	New	+$1.58M	0.02%	402

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Laurion Capital Management's EVH Position: Q2 2019 in Review

Laurion Capital Management sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 32,968 shares — an estimated $415K sold.

Laurion Capital Management first reported a position in EVH in Q2 2015 and held it in 6 quarters. The position peaked at $8.54M in Q1 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Laurion Capital Management reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Laurion Capital Management sold 32,968 Evolent Health shares in Q2 2019, an estimated $415K.
Laurion Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 6 quarters.
Laurion Capital Management's Evolent Health position peaked at $8.54M in Q1 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.